Literature DB >> 10956408

Prognostic significance of the Ca(2+) binding protein S100A2 in laryngeal squamous-cell carcinoma.

L Lauriola1, F Michetti, N Maggiano, J Galli, G Cadoni, B W Schäfer, C W Heizmann, F O Ranelletti.   

Abstract

We investigated by immunocytochemistry the expression of the Ca(2+) binding protein S100A2 in 62 cases of laryngeal squamous-cell carcinoma (SCC). S100A2 was detected in 18/19 (95%) low-grade tumors and in 22/43 (51%) high-grade tumors, which were partially keratinizing. The remaining 21/43 (49%) high-grade tumors were non-keratinizing, anaplastic tumors and clearly S100A2-negative. In normal laryngeal squamous epithelium and in laryngeal SCC, S100A2 expression was strictly associated with that of cytokeratins 14 (P = 0.0002) and 17 (P = 0.0021), suggesting an association of S100A2 expression and cell commitment to squamous differentiation. A correlation was found between S100A2 tumor positivity and longer relapse-free (P = 0.0005) and overall (P = 0.0095) survival. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10956408     DOI: 10.1002/1097-0215(20000720)89:4<345::aid-ijc5>3.0.co;2-t

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  15 in total

1.  Expression and clinical significance of S100A2 and p63 in esophageal carcinoma.

Authors:  Li-Yu Cao; Yu Yin; Hao Li; Yan Jiang; Hong-Fu Zhang
Journal:  World J Gastroenterol       Date:  2009-09-07       Impact factor: 5.742

Review 2.  S100A2 protein and non-small cell lung cancer. The dual role concept.

Authors:  Panagiotis Hountis; Dimitrios Matthaios; Marios Froudarakis; Demosthenes Bouros; Stylianos Kakolyris
Journal:  Tumour Biol       Date:  2014-05-27

3.  Clinical significance of S100A2 expression in gastric cancer.

Authors:  Ying-Fu Liu; Qing-Qing Liu; Xuan Wang; Chun-Hua Luo
Journal:  Tumour Biol       Date:  2013-12-07

4.  Significance of S100A2 and S100A4 Expression in the Progression of Prostate Adenocarcinoma.

Authors:  Yong-Wook Kwon; In Ho Chang; Kyung Do Kim; Young Sun Kim; Soon-Chul Myung; Mi-Kyung Kim; Tae-Hyoung Kim
Journal:  Korean J Urol       Date:  2010-07-20

5.  S100A6 expression and function in human osteosarcoma.

Authors:  Xiaoji Luo; Katie A Sharff; Jin Chen; Tong-Chuan He; Hue H Luu
Journal:  Clin Orthop Relat Res       Date:  2008-07-09       Impact factor: 4.176

Review 6.  Predictive factors of neck metastases in laryngeal squamous cell carcinoma. Towards an integrated clinico-molecular classification.

Authors:  G Almadori; F Bussu; G Paludettii
Journal:  Acta Otorhinolaryngol Ital       Date:  2006-12       Impact factor: 2.124

7.  Epigenetic silencing of S100A2 in bladder and head and neck cancers.

Authors:  Juna Lee; Piotr T Wysocki; Ozlem Topaloglu; Leonel Maldonado; Mariana Brait; Shahnaz Begum; David Moon; Myoung Sook Kim; Joseph A Califano; David Sidransky; Mohammad O Hoque; Chulso Moon
Journal:  Oncoscience       Date:  2015-03-16

8.  iTRAQ-based quantitative proteomic analysis on S100 calcium binding protein A2 in metastasis of laryngeal cancer.

Authors:  Cong Zha; Xue Hua Jiang; Shi Fang Peng
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

9.  S100A2 is strongly expressed in airway basal cells, preneoplastic bronchial lesions and primary non-small cell lung carcinomas.

Authors:  S L Smith; M Gugger; P Hoban; D Ratschiller; S G Watson; J K Field; D C Betticher; J Heighway
Journal:  Br J Cancer       Date:  2004-10-18       Impact factor: 7.640

10.  Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site.

Authors:  Ralf D Kirschner; Katja Sänger; Gerd A Müller; Kurt Engeland
Journal:  Nucleic Acids Res       Date:  2008-04-03       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.